Literature DB >> 9648075

No net renal extraction of homocysteine in fasting humans.

C van Guldener1, A J Donker, C Jakobs, T Teerlink, K de Meer, C D Stehouwer.   

Abstract

BACKGROUND: The pathophysiological mechanism of hyperhomocysteinemia in chronic renal failure in humans is unknown. The loss of a putative renal homocysteine extraction in chronic renal failure has been hypothesized as significant homocysteine uptake has been demonstrated in the normal rat kidney. We studied homocysteine extraction in the normal human kidney.
METHODS: We measured plasma total (free and protein-bound) and free homocysteine (tHcy and fHcy, respectively) in arterial and renal venous blood sampled from the aorta and right-side renal vein during cardiac catheterization in 20 fasting patients with normal renal function. Renal homocysteine extraction was calculated as the arteriovenous difference divided by the arterial levels times 100%.
RESULTS: No significant renal extraction was demonstrated either for tHcy: 0.9% (SD 5.8; 95% CI -1.8 to +3.6) or for fHcy: -0.2% (11.0; -5.4 to +4.9).
CONCLUSIONS: We conclude that no significant net renal uptake of homocysteine occurs in fasting humans with normal renal function. The loss of such uptake, therefore, cannot cause hyperhomocysteinemia in patients with renal failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648075     DOI: 10.1046/j.1523-1755.1998.00983.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent.

Authors:  Daniela Giustarini; Paolo Fanti; Anna Sparatore; Elena Matteucci; Ranieri Rossi
Journal:  Biochem Pharmacol       Date:  2014-03-14       Impact factor: 5.858

Review 2.  Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors:  D A Stehouwer
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

3.  The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort.

Authors:  Eytan Cohen; Ili Margalit; Tzippy Shochat; Elad Goldberg; Ilan Krause
Journal:  J Nephrol       Date:  2019-06-05       Impact factor: 3.902

Review 4.  Homocysteine and coronary risk.

Authors:  N Seshadri; K Robinson
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

5.  Homocysteine, folate, vitamin B12 levels, and C677T MTHFR mutation in children with renal failure.

Authors:  Alberto Canepa; Alba Carrea; Gianluca Caridi; Laura Dertenois; Giuseppe Minniti; Roberto Cerone; Silvana Canini; Maria Grazia Calevo; Francesco Perfumo
Journal:  Pediatr Nephrol       Date:  2003-02-21       Impact factor: 3.714

Review 6.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.